PAIGE SNIKERIS: Open Payments
NPI 1013550672 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,879 in 173 payments from 17 companies in 2025. Trend: 2023 $7,302 · 2024 $4,091 · 2025 $3,879
Food & beverage: $3,694Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $740 |
| GENZYME CORPORATION | 13 | $434 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $408 |
| Janssen Biotech, Inc. | 14 | $367 |
| Arcutis Biotherapeutics, Inc. | 19 | $346 |
| Lilly USA, LLC | 11 | $325 |
| PFIZER INC. | 24 | $307 |
| Organon LLC | 15 | $272 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 10 | $149 |
| UCB, Inc. | 3 | $146 |
Products named: DUPIXENT, BOTOX, TREMFYA, Zoryve, CIBINQO, ILUMYA, VTAMA, EBGLYSS.
Industry payments across TX — which companies pay providers there.
